Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:PG

Procter & Gamble (PG)

150.33
-0.05 (0.03%)
as of Jun 18, 2026, 11:39:10 pm Market Open.
135 watching
0
WEAK BUY
Clearly they are impacted by a global slowdown, but not as much as the cyclical. Valuation is a little high, safe company with some growth but a safe one to own, He would prefer to play autos or housing.
DON'T BUY
A little rich. Classic consumer staple. Where there is a lot of nervousness, they hide or camp out in what they think is safe.
DON'T BUY
Possibly greatest marketing company in the world. Very safe company, but not the cheapest. You wont get great capital appreciation at these levels. There are more attractive places to be. It is a more defensive place to be.
HOLD
Provides a pretty decent dividend at 2.1%. Hasn't grown much over the last few years but it hasn't lost you money. It's a nice play on rising living standards in emerging markets.
PAST TOP PICK
(Top Pick May 5/11, Up 0.15%) sold it about 3 weeks later.
COMMENT
This is the sort of stock that is poised to do well in this kind of market. He doesn't care for it, because it is so big it is growth challenged. A good alternative might be Unilever (UL-N).
WEAK BUY
An orphans and widows stock and you can't really go wrong. It is a Buy but you are not going to make a lot of money on it. Making a lot of movement into the emerging markets.
TOP PICK
This is a time period when you want to favour defensive stocks. Brand power is extremely strong. Stock is very close to the top of where it was a few months ago but it is the beginning of its seasonality so he is not too concerned. If it comes back down, he’ll reassess.
COMMENT
Proctor & Gamble (PG-N) and Colgate Palmolive (CL-N) are both high quality consumer staple names. This one decided not to increase prices as quickly as others so their volume has suffered. A great long-term hold. Product innovation is quite good. If the market turns a bit more defensive, this could be a safe one to get into. About 35% emerging market exposure.
HOLD
Defensive play in an environment where it is not being rewarded. Trades at a fairly high multiple. Not performing well but still fairly rich. OK for a portfolio but don’t overweight.
BUY
Good international exposure and ability to participate in the emerging market growth.
COMMENT
Stable earnings grower. At this point in the cycle you want to be in more cyclical names than consumer staples. This one has safety and gradual growth. Has under performed the S&P 500 in the last 6-12 months.
DON'T BUY
Great company, very well managed. Today and for along while has represented a defensive play. Struggles to grow revenue and earnings. It’s an expensive stock and doesn’t warrant owning the company. It’s going to have its place in a particular cycle.
BUY
In this economy and market, this is a defensive company. You can’t go wrong here.
DON'T BUY
Money flow had gone to these areas because it was a place to hide. He is staying away from defensive areas. Too expensive at 16X earnings. Struggling for revenue and earnings growth.
Showing 121 to 135 of 208 entries